Phase II Clinical and Pharmacologic Study of Radiation Therapy and CAI (Carboxy-Amido Triazole) in Adults With Newly Diagnosed Glioblastoma Multiforme
Phase of Trial: Phase II
Latest Information Update: 14 May 2015
At a glance
- Drugs L 651582 (Primary)
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 02 May 2012 Additional lead trial centre added as reported by ClinicalTrials.gov.
- 02 Feb 2010 Actual end date (January 2010) added as reported by ClinicalTrials.gov.
- 02 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.